The added value of SPECT/CT with radioactive iodine whole body scanning in patients with differentiated thyroid cancer and its impact on TNM staging

The Role of 131I SPECT-CT as a Diagnostic Tool in Management of Patients with Differentiated Thyroid Cancer

Prognostic Value of FDG PET/CT in Differentiated Thyroid Cancer Patients

Value of F-18 FDG PET/CT Compared to Conventional Imaging in changing management of Patients with Differentiated Thyroid Cancer before radioactive iodine ablation.

I-131 Avid Versus FDG avid Loco-Regional Recurrent Differentiated Thyroid Carcinoma;Clinic-Pathological, Diagnostic & Therapy Outcome Differences

The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma

Value of Initial 18F-FDG PET/CT in Change of Management of Patients with Differentiated Thyroid Cancer as Compared to Post Ablative Whole Body Iodine Scan.

Impact of Post-Thyroidectomy I-123 Versus I-131 Whole Body Scan on the Outcome of Radioactive Iodine (I-131) Ablation for Differentiated Thyroid Carcinoma

Added Value of SPECT/CT in Characterization of Extra-Skeletal Uptake of Tc-99m MDP on Planar Bone Scintigraphy in Known Cancer Patients.

Added Value of SPECT/CT to Planar Bone Scan in Evaluation of Suspicious Metastatic Bony Lesions in Breast Cancer.